This brand name is authorized in Croatia, Romania
The drug PYZYPI contains one active pharmaceutical ingredient (API):
|
1
Pazopanib
UNII 33Y9ANM545 - PAZOPANIB HYDROCHLORIDE
|
|
Pazopanib is an orally administered, potent multi-target tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptors (VEGFR) -1, -2, and -3, platelet-derived growth factor (PDGFR) -α and -β, and stem cell factor receptor (c-KIT), with IC50 values of 10, 30, 47, 71, 84 and 74 nM, respectively. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01EX03 | Pazopanib | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-157134779, HR-H-170459948 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68700001, W68700002, W68700003, W68700004, W68700005, W68700006, W68700007, W68700008, W68700009, W68700010, W68700011, W68700012, W68700013, W68701001, W68701002, W68701003, W68701004, W68701005, W68701006, W68701007, W68701008, W68701009, W68701010, W68701011, W68701012 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
